In this study, we combined whole-transcriptome sequencing and proteomic analysis to further investigate the mechanism through which SPAM1 exerts neuroprotective effects, thereby laying the pharmacological foundation for the use of SPAM1 as a therapeutic agent for neurodegenerative diseases. This evidence concerns the gene SPAM1 and neurodegenerative disease.